Article Versions Notes

Rossmueller G, Mirkina I, Thiele M, Puchol Tarazona A, Rueker F, Kerschbaumer RJ, Schinagl A. Integrating In Silico and In Vitro Tools for Optimized Antibody Development—Design of Therapeutic Anti-oxMIF Antibodies. Antibodies. 2024; 13(4):104. https://doi.org/10.3390/antib13040104

Rossmueller, Gregor, Irina Mirkina, Michael Thiele, Alejandro Puchol Tarazona, Florian Rueker, Randolf J. Kerschbaumer, and Alexander Schinagl. 2024. "Integrating In Silico and In Vitro Tools for Optimized Antibody Development—Design of Therapeutic Anti-oxMIF Antibodies" Antibodies 13, no. 4: 104. https://doi.org/10.3390/antib13040104

Rossmueller, G., Mirkina, I., Thiele, M., Puchol Tarazona, A., Rueker, F., Kerschbaumer, R. J., & Schinagl, A. (2024). Integrating In Silico and In Vitro Tools for Optimized Antibody Development—Design of Therapeutic Anti-oxMIF Antibodies. Antibodies, 13(4), 104. https://doi.org/10.3390/antib13040104